Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Invested Capital: 2022

  • Cullinan Therapeutics' Return on Invested Capital was N/A to 0.19% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.19%, marking a year-over-year change of. This contributed to the annual value of 0.22% for FY2022, which is N/A change from last year.
  • According to the latest figures from Q4 2022, Cullinan Therapeutics' Return on Invested Capital is 0.19%.
  • In the past 5 years, Cullinan Therapeutics' Return on Invested Capital ranged from a high of 0.19% in Q4 2022 and a low of 0.19% during Q4 2022.
  • Its 1-year average for Return on Invested Capital is 0.19%, with a median of 0.19% in 2022.